Kazazian Asset Management, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 224 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
Kazazian Asset Management, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2019$563,000
-22.1%
7,6620.0%0.76%
-11.3%
Q2 2019$723,000
+4.3%
7,662
-11.5%
0.86%
-11.0%
Q1 2019$693,000
-30.6%
8,662
-53.2%
0.96%
-28.7%
Q4 2018$999,000
-55.9%
18,528
-36.2%
1.35%
-36.4%
Q3 2018$2,267,000
+23.0%
29,0360.0%2.12%
+25.7%
Q2 2018$1,843,000
-29.8%
29,036
+1.4%
1.69%
-38.6%
Q1 2018$2,627,000
+21.6%
28,6460.0%2.75%
+24.7%
Q4 2017$2,160,000
+25.4%
28,646
+15.8%
2.21%
+4.6%
Q3 2017$1,723,000
+46.1%
24,735
+6.3%
2.11%
+18.2%
Q2 2017$1,179,00023,2731.78%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders